The inclusion of METTL9, a mitochondrial-associated methyltransferase, further supports the hypothesis that altered bioenergetics and redox imbalance contribute to persistent fatigue and cognitive dysfunction observed in post-acute sequelae of SARS-CoV-2 infection (PASC). The gene discussed is METTL9; the disease is long COVID-19.